Phospholipid composition of myocardium in children with normoxemic and hypoxemic congenital heart diseases

Physiological Research

Volumn 53, Issue 5, 2004, Pages 557-560

  Hamplova B ^a   Pelouch, V ^a   Novakova O ^a   Skovranek J ^a   Hucin B ^a   Novak F ^a,b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atrium; Congenital heart disease; Human myocardium; Phospholipids; Ventricle

Indexed keywords

PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID;

ADAPTATION; AEROBIC METABOLISM; ARTICLE; BLOOD OXYGENATION; CELL DEATH; CHEMICAL COMPOSITION; CONGENITAL HEART DISEASE; EXTRACELLULAR MATRIX; HEART SURGERY; HEART VENTRICLE; HUMAN; HUMAN TISSUE; HYPOXEMIA; OXYGEN SATURATION; PHOSPHOLIPID MEMBRANE;

ANOXEMIA; CHILD; FEMALE; HEART ATRIA; HEART DEFECTS, CONGENITAL; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; ORGAN SPECIFICITY; PHOSPHOLIPIDS; TISSUE DISTRIBUTION;

EID: 8444238620     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. BASS A, ŠAMÁNEK M, OŠŤÁDAL B, HUČÍN B, STEJSKALOVÁ M, PELOUCH V: Differences between atrial and ventricular energy supplying enzymes in children. J Appl Cardiol 3: 397-405, 1988.
2. FOLCH J, LEES M, SLOAN-STANLEY GH: A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226: 497-509, 1957.
3. GUDBJARNASON S: Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle. J Intern Med 225: 117-128, 1989.
4. MAULIK N, KAGAN VE, TYURIN VA, DAS DK: Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol 274: H242-H248, 1998.
5. NOVÁKOVÁ O, MRNKA L, PELOUCH V, KALOUS M, NOVAK F: Altered phospholipid composition and oxidative capacity in pressure-overloaded rat myocardium. J Mol Cell Cardiol 27: A85, 1995.
6. PELOUCH V, MILEROVÁ M, OŠŤÁDAL B, ŠAMÁNEK M, HUČÍN B: Protein profiling of human atrial and ventricular musculature: the effect of normoxaemia and hypoxaemia in congenital heart diseases. Physiol Res 42: 235-242, 1993.
7. PELOUCH V, MILEROVÁ M, OŠŤÁDAL B, ŠAMÁNEK M, HUČÍN B: Collagenous and noncollagenous proteins of human atrial and ventricular musculature: the effect of normoxaemia and hypoxaemia in congenital heart disease. J Muscle Res Cell Motil 16: 171-172, 1995a.
8. PELOUCH V, MILEROVÁ M, OŠŤÁDAL B, HUČÍN B, ŠAMÁNEK M: Differences between atrial and ventricular protein profiling in children with congenital heart disease. Mol Cell Biochem 147: 43-49, 1995b.
9. PELOUCH V, PEXIEDER T, MILEROVÁ M, OŠŤÁDAL B, ŠAMÁNEK M: Protein remodeling of malformed human and mouse heart. In: The Developing Heart. B OŠŤÁDAL, M NAGANO, N TAKEDA, NS DHALLA (eds), Raven Press, New York, 1997, pp 357-372.
10. ROCQUELIN G, GUENOT L, ASTORG PO, DAVID M: Phospholipid content and fatty acid composition of human heart. Lipids 24: 775-780, 1989.
11. ROUSER G, FLEISCHER S, YAMAMOTO A: Two dimensional thin layer Chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5: 494-496, 1970.
12. 3-TLC/FID and ozonolysis. Lipids 17: 469-475, 1982.
13. SKULADOTTIR G, BENEDIKTSDOTTIR E, HARDARSON T, HALLGRIMSSON J, ODDSSON G, SIGFUSSON N, GUDBJARNASON S: Arachidonic acid level of non-esterified fatty acid and phospholipids in serum and heart muscle of patients with fatal mycocardial infarction. Acta Med Scand 223: 233-238, 1988.